Prostatype Genomics AB (publ) at its annual general meeting held on June 2, 2022, Mattias Prage was elected as new member of the board.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0575 SEK | -7.26% | +0.88% | -39.47% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-39.47% | 5.83M | |
-24.66% | 7.76B | |
+68.82% | 4.33B | |
-3.50% | 2.64B | |
+3.74% | 2.63B | |
-46.17% | 2.16B | |
-14.37% | 1.75B | |
-19.73% | 1.46B | |
+13.62% | 1.17B | |
-43.81% | 1.14B |
- Stock Market
- Equities
- PROGEN Stock
- News Prostatype Genomics AB
- Prostatype Genomics AB Appoints Mattias Prage as Member of the Board